Concepedia

Feliciano Barrón

FB

Statistics

Publications

20

Citations

922

H-Index

15

Active since

2016

Affiliations

Instituto Nacional de Cancerología(Current)

Foundation for Clinical and Applied Cancer Research

Universidad El Bosque

Institut Català d'Oncologia

Instituto Alexander Fleming

Feliciano Barrón is an author at Instituto Nacional de Cancerología specializing in lung cancer, medicine, and oncology.

ORCID

Top concepts

Publications per year

2016–2023

20

Publications

20

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma

Óscar Arrieta, Feliciano Barrón, M. Salinas Padilla et al. · JAMA Oncology · 2019 · 181 citations · Full text

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non–Small Cell Lung Cancer

Óscar Arrieta, Feliciano Barrón, Zyanya Lucía Zatarain-Barrón et al. · JAMA Oncology · 2020 · 149 citations · Full text

The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial

Jenny G. Turcott, María del Rocío Guillen Núñez, Diana Flores‐Estrada et al. · Supportive Care in Cancer · 2018 · 115 citations

, , +9

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Diego de Miguel‐Pérez, Alessandro Russo, Óscar Arrieta et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 97 citations · Full text

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona et al. · Thoracic Cancer · 2019 · 60 citations · Full text

1–5 of 20